Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Blueprint Medicines (BPMC) Enters $1.25B Strategic Financing Collaborations with Sixth Street and Royalty Pharma (RPRX)
-
Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations with Sixth Street and Royalty Pharma
-
Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference
-
Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference
-
Royalty Pharma plc (RPRX) Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst (BCRX) for $350M
-
Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
-
Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
-
BioCryst Pharma (BCRX) Adds $350 Million in New Financing with Royalty Pharma (RPRX) and OMERS Capital Markets
-
BioCryst Pharma (BCRX) Announces $325 Million of Funding from Royalty Pharma (RPRX) and Athyrium Capital Management
-
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
-
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
-
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
-
Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma plc (RPRX) Prices 17.34M Class A Share Secondary Offering at $42/Sh by Selling Shareholders
-
Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma (RPRX) Announces 17.3M Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders
-
Cowen Starts Royalty Pharma (RPRX) at Outperform
-
Royalty Pharma Announces Closing of Initial Public Offering
-
Royalty Pharma Announces Closing of Initial Public Offering
-
Royalty Pharma plc (RPRX) IPO Opens 57% Higher
-
Pre-Open Stock Movers 09/08: (RPRX) (RAD) (JUNO) Higher; (GEVO) (NLST) (TSCO) (PIR) Lower (more...)
-
Pre-Open Stock Movers 10/17: (ESI) (SRPT) (QLGC) Higher; (RPRX) (URBN) (MYGN) Lower
-
Pre-Open Stock Movers 9/26: (JNS) (NKE) (MU) Higher; (ACRX) (FINL) (BBRY) Lower (more...)